This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Calliditas Therapeutics Suisse Sa, University of Southampton. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 252 
Years Active: 2024
Title: Christopher Hanley: Innovator in Cancer Treatment
Introduction
Christopher Hanley is a notable inventor based in Southampton, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the effectiveness of immunotherapy, particularly in restoring responsiveness to various cancer treatments.
Latest Patents
Hanley holds a patent for the "Use of NOX inhibitors for treatment of cancer." This invention relates to compounds, methods, compositions, and uses that can restore responsiveness to immunotherapy, specifically immune checkpoint inhibitors or anti-cancer vaccines, as well as anti-angiogenesis treatments. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Hanley has worked with prominent organizations, including Calliditas Therapeutics Suisse SA and the University of Southampton. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Kirsty Ford and Freddy Heitz. Their collaborative efforts have furthered the development of innovative solutions in cancer treatment.
Conclusion
Christopher Hanley is a dedicated inventor whose work in cancer treatment exemplifies the potential of innovative research. His contributions are paving the way for more effective therapies in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile